VIVIMED LABS LIMITED
Latest filings
- Exchange seeks clarification on modified audit opinion disclosure · Regulatory & Legal
- Vivimed Labs FY26 results filed under CIRP, auditor gives qualified opinion · Results
- Vivimed Labs 8th Committee of Creditors meeting scheduled for Sep 29, 2026 · Regulatory & Legal
Snapshot
What the business is, and whether it's a good one at a fair price.
Manufactures pharmaceutical dosages at four plants in Hyderabad, Haridwar, Kashipur, and Bidar, with 352 employees reported as part of the insolvency filings. Standalone FY25 revenue is reported at ₹116.269 crore, while a related filing cited FY25 revenue of ₹103.6 crore against ₹136.8 crore in FY24; standalone revenue for the nine months ended December 2025 was ₹48.23 crore. The cost structure is materials-heavy at 49.7% of revenue, followed by employee costs at 24.4% and other opex at 34.9% of revenue. The NCLT Bengaluru Bench admitted the company into Corporate Insolvency Resolution Process on April 15, 2026, following a petition by Blue Cube Germany Assets GmbH, an operational creditor, for unpaid debt of ₹32.79 crore from chemical supplies made in 2012-2014. The board has been suspended, an Interim Resolution Professional has been appointed, and a CBI investigation is pending; the statutory auditor has flagged going-concern uncertainty, unrecorded interest of ₹626 million, and confirmed that all loans are non-performing assets.
Scorecard
Measured from the filed financials · as of FY25 — not investment advice
Strengths
Nothing stands out in the filed numbers.Concerns
Charts
How has the market priced it — with filings on the timeline?
VIVIMEDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from VIVIMED LABS LIMITED's filed financials and exchange disclosures
What does VIVIMED LABS LIMITED do?
VIVIMED LABS LIMITED is listed on NSE and BSE, trading under the symbol VIVIMEDLAB.
Is VIVIMED LABS LIMITED debt-free?
No. It reported borrowings of ₹384 Cr on its 30 Sept 2025 balance sheet, or net debt of ₹383 Cr after cash. Its net worth is negative — liabilities exceed assets by ₹48 Cr, so a debt-to-equity ratio is not meaningful.
How much does the VIVIMED LABS LIMITED share price move in a day?
On a typical session VIVIMED LABS LIMITED moves 2.35% — that is the median absolute close-to-close move across its last 216 trading days. MarketPing measures each filing's price reaction against it.
Where can I track VIVIMED LABS LIMITED's announcements?
Every NSE and BSE filing by VIVIMED LABS LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.